lactic acid has been researched along with loperamide in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (27.27) | 29.6817 |
| 2010's | 8 (72.73) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Bertolini, A; Costantino, L; Forni, F; Leo, E; Rivasi, F; Ruozi, B; Tacchi, R; Tosi, G; Vandelli, MA; Vergoni, AV | 1 |
| Dalwadi, G; Sunderland, VB | 1 |
| Dalwadi, G; Sunderland, B | 1 |
| Black, D; James, PD; Kuper, A; Saibil, F | 1 |
| Badiali, L; Bondioli, L; Costantino, L; Forni, F; Rivasi, F; Ruozi, B; Tosi, G; Vandelli, MA; Vergoni, AV | 1 |
| Choi, JH; Jeon, JR | 1 |
| Badiali, L; Benassi, R; Bondioli, L; Fano, RA; Forni, F; Rivasi, F; Ruozi, B; Tosi, G; Vandelli, MA | 1 |
| Chen, YC; Hsieh, WY; Lee, WF; Zeng, DT | 1 |
| Al Baharna, M; Chen, CN; Kirby, BP; Pabari, R; Ramtoola, Z; Walsh, J | 1 |
| Baneham, S; Cox, D; Kirby, BP; Moollan, A; O'Donnell, A; Ozgul, M; Pabari, RM; Ramtoola, Z | 1 |
11 other study(ies) available for lactic acid and loperamide
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Targeting the central nervous system: in vivo experiments with peptide-derivatized nanoparticles loaded with Loperamide and Rhodamine-123.
Topics: Animals; Antidiarrheals; Blood-Brain Barrier; Brain; Drug Delivery Systems; Lactic Acid; Loperamide; Male; Nanoparticles; Oligopeptides; Pain Measurement; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Rats; Rats, Wistar; Rhodamine 123 | 2007 |
Purification of PEGylated nanoparticles using tangential flow filtration (TFF).
Topics: Dextran Sulfate; Excipients; Filtration; Lactic Acid; Loperamide; Nanoparticles; Polyethylene Glycols; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Polyvinyl Alcohol; Sodium Cholate; Surface-Active Agents | 2007 |
An ion pairing approach to increase the loading of hydrophilic and lipophilic drugs into PEGylated PLGA nanoparticles.
Topics: Analgesics; Antidiarrheals; Chemistry, Pharmaceutical; Dextran Sulfate; Drug Carriers; Enkephalin, Leucine-2-Alanine; Hydrophobic and Hydrophilic Interactions; Lactic Acid; Loperamide; Molecular Weight; Nanoparticles; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Solvents | 2009 |
D-lactic acidosis and ataxia in a man with Crohn disease.
Topics: Acidosis, Lactic; Anti-Inflammatory Agents; Antidiarrheals; Ataxia; Crohn Disease; Diagnosis, Differential; Humans; Intestinal Mucosa; Intestines; Lactic Acid; Loperamide; Male; Middle Aged; Prednisone; Vitamins | 2010 |
Sialic acid and glycopeptides conjugated PLGA nanoparticles for central nervous system targeting: In vivo pharmacological evidence and biodistribution.
Topics: Animals; Brain; Drug Carriers; Glycopeptides; Lactic Acid; Loperamide; Male; Microscopy, Electron, Scanning; N-Acetylneuraminic Acid; Nanoparticles; Organ Specificity; Pain; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Rats; Rats, Inbred Strains; Surface Properties; Tissue Distribution | 2010 |
Lactic acid fermentation of germinated barley fiber and proliferative function of colonic epithelial cells in loperamide-induced rats.
Topics: Animals; Bacteria; Bifidobacterium; Cell Proliferation; Colon; Constipation; Dietary Fiber; Disease Models, Animal; Epithelial Cells; Fermentation; Germination; Hordeum; Humans; Lactic Acid; Lactobacillus acidophilus; Loperamide; Male; Rats; Rats, Sprague-Dawley; Streptococcus thermophilus; Yogurt | 2010 |
Investigation on mechanisms of glycopeptide nanoparticles for drug delivery across the blood-brain barrier.
Topics: Animals; Blood-Brain Barrier; Drug Delivery Systems; Glycopeptides; Lactic Acid; Loperamide; Male; Nanoparticles; Neurodegenerative Diseases; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Rats; Rats, Wistar; Rhodamine 123; Tissue Distribution | 2011 |
Effects of surface modification of PLGA-PEG-PLGA nanoparticles on loperamide delivery efficiency across the blood-brain barrier.
Topics: Animals; Antidiarrheals; Blood-Brain Barrier; Cell Line; Drug Carriers; Lactic Acid; Loperamide; Male; Mice; Nanoparticles; Poloxamer; Polyethylene Glycols; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polysorbates; Rats; Surface Properties; Surface-Active Agents | 2013 |
Comparative evaluation of the degree of pegylation of poly(lactic-co-glycolic acid) nanoparticles in enhancing central nervous system delivery of loperamide.
Topics: Administration, Intranasal; Animals; Brain; Caco-2 Cells; Cell Survival; Drug Carriers; Drug Compounding; Endocytosis; Humans; Lactic Acid; Loperamide; Mice; Mice, Inbred C57BL; Nanoparticles; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Solubility; Surface Properties | 2013 |
Intranasal and intravenous administration of octa-arginine modified poly(lactic-co-glycolic acid) nanoparticles facilitates central nervous system delivery of loperamide.
Topics: Administration, Intranasal; Administration, Intravenous; Analgesics; Animals; Arginine; Cell Line; Central Nervous System; Coumarins; Dogs; Drug Delivery Systems; Female; Lactic Acid; Loperamide; Male; Mice, Inbred C57BL; Nanoconjugates; Nanoparticles; Particle Size; Polyesters; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Thiazoles | 2015 |